Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis
Sign Up to like & getrecommendations! Published in 2018 at "Medical Oncology"
DOI: 10.1007/s12032-018-1142-3
Abstract: Cholinergic syndrome is an acute adverse reaction associated with irinotecan. Development of cholinergic syndrome can be ameliorated or prevented by administering various anticholinergics, including atropine sulfate or scopolamine butylbromide. Although many of the side effects… read more here.
Keywords: analysis; development irinotecan; cholinergic syndrome; syndrome ... See more keywords
Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine
Sign Up to like & getrecommendations! Published in 2018 at "Psychogeriatrics"
DOI: 10.1111/psyg.12341
Abstract: Decreased levels of acetylcholine contribute to cognitive dysfunction in Alzheimer’s disease (AD). Acetylcholinesterase (AChE) inhibitors prevent the degradation of acetylcholine by inhibiting the enzyme AChE, resulting in increased levels of acetylcholine in the synaptic endings.… read more here.
Keywords: galantamine; day; cholinergic syndrome; acute cholinergic ... See more keywords
Relation between irinotecan-induced cholinergic syndrome and prognosis of colorectal cancer patients.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.859
Abstract: 859Background: It is well known that a cetuximab induced rash is strongly associated with improved survival of colorectal cancer patients. Irinotecan Induced Cholinergic Syndrome (IICS), manifestin... read more here.
Keywords: cancer patients; irinotecan induced; colorectal cancer; cholinergic syndrome ... See more keywords